CHIEF EXECUTIVE OFFICER
Niaz Karim is Chief Executive Officer of Intelon Optics. Niaz’s background spans venture capital, technology licensing and new venture formation.
Niaz is a partner at Valmo Ventures, an investment and advisory firm, where he manages portfolio interests in the medical device, media and technology areas. Previously, Niaz was part of the Harvard University team that commercially licensed Harvard innovations to industry. He was also part of the venture capital teams at Commons Capital and the Massachusetts Green Energy Fund, where he focused on investment sourcing and due diligence in the areas of healthcare, clean energy, education technology and consumer products.
Niaz’s non-profit passions include empowering young people with educational opportunity and experiences that help them to reach their potential. He co-founded efforts that teach students about personal finance and investing. The Financial Fluency Program, a collaboration of numerous not-for-profits, has been used in schools in Massachusetts, Connecticut, Maine, Rhode Island, Vermont and New Hampshire.
Niaz has been published in refereed scientific journals, has worked on economic development and relief work in Kosovo and the Republic of Congo, and has worked with Seeds of Peace, an international organization focused on youth peace-building in conflict areas around the world.
Niaz received his Bachelor of Arts in Economics from Dartmouth College.
Dimitri Chernyak, phd,
Vice-President of Engineering
Dimitri leads research, development and engineering efforts at Intelon Optics. Dimitri most recently served as Director of Research at Abbott Medical Optics (now Johnson & Johnson Vision), the global leader in refractive surgery equipment. At Abbott Medical Optics, he led development, feasibility, design and validation of laser vision correction products, and coordinated data analysis for continuous improvements in laser vision correction outcomes. At Abbot-AMO, he also advised Senior Management, Business Development and Legal on IP, oversaw joint research programs with academic institutions, and was a spokesmen for the company at scientific meetings and professional conferences.
Prior to Abbott-AMO, he was Manager of Scientific Research and Staff Research Scientist at VISX, the laser refractive surgery technology acquired by Abbott-AMO. Dimitri brings expertise in developing next generation refractive diagnostic technologies and refining laser-tissue interaction based on data.
Dimitri has 15+ years of experience in developing diagnostic and surgical devices in ophthalmology and has been Scientific Advisor to OptoQuest, a biomechanical modeling company and spin-off of the Cleveland Clinic Eye Center, Cleveland, OH as well as Scientific Advisor to Apixio, a Menlo Park, California, based medical software and data analytics company.
Dimitri earned a PhD in Vision Science at UC Berkeley in 2001. His research was centered on modeling of attention, eye movements and object recognition. Born in Moscow, Russia, he attended the Biology Department of Moscow State University, and in 1992 received a BA degree from Brandeis University, Waltham, MA, in Mathematics and Biology. In 1994, he was awarded an MA degree in Cognitive and Neural Systems from Boston University. His research has been supported by grants from NIH, NASA and American Optometry Foundation Ezell Fellowship. He has authored numerous articles in the field of refractive diagnostic and surgery technology and has filed multiple patents related to this area of research.
Maxwell Kotlarchyk, phd
director of biomedical and systems engineering
Max leads BOSS prototyping and product development project efforts spanning internal and external development efforts. Most recently, Max, was principal lead biomedical engineer and project manager at Optimum Technologies Inc., a biomedical and optical systems development and consulting firm based in Massachusetts. Max has a strong track record in electro- and opto-/mechanical system design, laser-based visualization systems for diagnostic and surgical applications, and biomechanics.
Max earned a PhD in Biomedical Engineering at UC Irvine. He designed and built laser microscopy systems for studying the biomechanical interactions between cells and their surrounding extracellular matrix (ECM). His research was performed both at the Beckman Laser Institute, the Edwards LifeSciences Center, and the Laboratory for Quantitative Fluorescence. This fundamental research explored the structure-function relationship in the expression of vascular phenotypes in 3D tissue engineered ECM’s. Max received a BS degree in Biomedical Engineering from Case Western University and a MS in Biomedical Engineering from UC Irvine.
Andrew shin, phd
Andrew is Senior Engineer at Intelon Optics, where he plays a critical role in prototype development, commercial development, and clinical development transfer. Andrew combines a strong background in mechanical engineering, ocular imaging, and a passion for commercial innovation and patient benefit.
As Fellow and Project Scientist at the Jules Stein Eye Institute, Andrew specialized in soft tissue biomechanics as applied to ophthalmology including a focus on the sclera, extra-ocular muscle and tendon. In addition, he completed experimental studies to characterize biomechanical behavior related to the pathogenesis of glaucoma and tissue behavior at the interface of biomechanics and optical coherence tomography (OCT). He has published papers in journals such as the American Journal of Ophthalmology, the Journal of Biomechanics, and Investigative Ophthalmology and Visual Sciences (IOVS), spanning topics such as the optomechanical properties of the sclera and deformation of the optic nerve head in glaucoma. Andrew graduated with his Ph.D. in mechanical engineering from UCLA and his Masters in Mechanical Engineering from KAIST in Daejeon, South Korea.